DAVITA INC (DVA) Stock Fundamental Analysis

NYSE:DVA • US23918K1088

151.28 USD
+0.55 (+0.36%)
At close: Feb 23, 2026
151.28 USD
0 (0%)
After Hours: 2/23/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to DVA. DVA was compared to 101 industry peers in the Health Care Providers & Services industry. While DVA belongs to the best of the industry regarding profitability, there are concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on DVA.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year DVA was profitable.
  • In the past year DVA had a positive cash flow from operations.
  • In the past 5 years DVA has always been profitable.
  • DVA had a positive operating cash flow in each of the past 5 years.
DVA Yearly Net Income VS EBIT VS OCF VS FCFDVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

1.2 Ratios

  • DVA's Return On Assets of 4.27% is fine compared to the rest of the industry. DVA outperforms 73.27% of its industry peers.
  • DVA's Return On Invested Capital of 11.22% is amongst the best of the industry. DVA outperforms 83.17% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for DVA is in line with the industry average of 8.93%.
  • The last Return On Invested Capital (11.22%) for DVA is above the 3 year average (10.38%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.27%
ROE N/A
ROIC 11.22%
ROA(3y)4.59%
ROA(5y)4.56%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.38%
ROIC(5y)9.62%
DVA Yearly ROA, ROE, ROICDVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 400 600

1.3 Margins

  • DVA's Profit Margin of 5.47% is amongst the best of the industry. DVA outperforms 81.19% of its industry peers.
  • In the last couple of years the Profit Margin of DVA has declined.
  • With an excellent Operating Margin value of 14.74%, DVA belongs to the best of the industry, outperforming 90.10% of the companies in the same industry.
  • In the last couple of years the Operating Margin of DVA has remained more or less at the same level.
  • Looking at the Gross Margin, with a value of 32.25%, DVA is in the better half of the industry, outperforming 61.39% of the companies in the same industry.
  • DVA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 14.74%
PM (TTM) 5.47%
GM 32.25%
OM growth 3Y9.25%
OM growth 5Y0.22%
PM growth 3Y4.31%
PM growth 5Y-3.96%
GM growth 3Y3.26%
GM growth 5Y0.9%
DVA Yearly Profit, Operating, Gross MarginsDVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • DVA has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, DVA has less shares outstanding
  • The number of shares outstanding for DVA has been reduced compared to 5 years ago.
  • DVA has a worse debt/assets ratio than last year.
DVA Yearly Shares OutstandingDVA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
DVA Yearly Total Debt VS Total AssetsDVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • Based on the Altman-Z score of 1.54, we must say that DVA is in the distress zone and has some risk of bankruptcy.
  • DVA has a Altman-Z score of 1.54. This is comparable to the rest of the industry: DVA outperforms 40.59% of its industry peers.
  • DVA has a debt to FCF ratio of 7.84. This is a slightly negative value and a sign of low solvency as DVA would need 7.84 years to pay back of all of its debts.
  • DVA's Debt to FCF ratio of 7.84 is in line compared to the rest of the industry. DVA outperforms 53.47% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 7.84
Altman-Z 1.54
ROIC/WACC1.43
WACC7.87%
DVA Yearly LT Debt VS Equity VS FCFDVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 1.29 indicates that DVA should not have too much problems paying its short term obligations.
  • DVA has a Current ratio (1.29) which is comparable to the rest of the industry.
  • DVA has a Quick Ratio of 1.24. This is a normal value and indicates that DVA is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of DVA (1.24) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.24
DVA Yearly Current Assets VS Current LiabilitesDVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • DVA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.37%, which is quite good.
  • The Earnings Per Share has been growing slightly by 7.46% on average over the past years.
  • Looking at the last year, DVA shows a small growth in Revenue. The Revenue has grown by 6.46% in the last year.
  • Measured over the past years, DVA shows a small growth in Revenue. The Revenue has been growing by 3.39% on average per year.
EPS 1Y (TTM)9.37%
EPS 3Y22.66%
EPS 5Y7.46%
EPS Q2Q%51.79%
Revenue 1Y (TTM)6.46%
Revenue growth 3Y5.53%
Revenue growth 5Y3.39%
Sales Q2Q%9.87%

3.2 Future

  • Based on estimates for the next years, DVA will show a very strong growth in Earnings Per Share. The EPS will grow by 20.56% on average per year.
  • The Revenue is expected to grow by 5.41% on average over the next years.
EPS Next Y27.29%
EPS Next 2Y23.63%
EPS Next 3Y24.56%
EPS Next 5Y20.56%
Revenue Next Year3.76%
Revenue Next 2Y3.4%
Revenue Next 3Y3.7%
Revenue Next 5Y5.41%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DVA Yearly Revenue VS EstimatesDVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B
DVA Yearly EPS VS EstimatesDVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30 40

More info and screens

Find the best growth stocksShow best growing peers

8

4. Valuation

4.1 Price/Earnings Ratio

  • DVA is valuated correctly with a Price/Earnings ratio of 14.56.
  • DVA's Price/Earnings ratio is rather cheap when compared to the industry. DVA is cheaper than 82.18% of the companies in the same industry.
  • DVA is valuated rather cheaply when we compare the Price/Earnings ratio to 26.64, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 11.44, which indicates a very decent valuation of DVA.
  • Based on the Price/Forward Earnings ratio, DVA is valued cheaply inside the industry as 85.15% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of DVA to the average of the S&P500 Index (27.75), we can say DVA is valued rather cheaply.
Industry RankSector Rank
PE 14.56
Fwd PE 11.44
DVA Price Earnings VS Forward Price EarningsDVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 83.17% of the companies in the same industry are more expensive than DVA, based on the Enterprise Value to EBITDA ratio.
  • 89.11% of the companies in the same industry are more expensive than DVA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 7.91
EV/EBITDA 7.29
DVA Per share dataDVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 -100

4.3 Compensation for Growth

  • DVA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of DVA may justify a higher PE ratio.
  • A more expensive valuation may be justified as DVA's earnings are expected to grow with 24.56% in the coming years.
PEG (NY)0.53
PEG (5Y)1.95
EPS Next 2Y23.63%
EPS Next 3Y24.56%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for DVA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DAVITA INC

NYSE:DVA (2/23/2026, 8:04:00 PM)

After market: 151.28 0 (0%)

151.28

+0.55 (+0.36%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-02
Earnings (Next)05-11
Inst Owners51.6%
Inst Owner Change0.17%
Ins Owners4.68%
Ins Owner Change-0.02%
Market Cap10.37B
Revenue(TTM)13.64B
Net Income(TTM)746.80M
Analysts52.94
Price Target141.8 (-6.27%)
Short Float %19.41%
Short Ratio6.23
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-15.32%
Min EPS beat(2)-37.31%
Max EPS beat(2)6.68%
EPS beat(4)3
Avg EPS beat(4)-6.2%
Min EPS beat(4)-37.31%
Max EPS beat(4)6.68%
EPS beat(8)5
Avg EPS beat(8)-2.1%
EPS beat(12)9
Avg EPS beat(12)2.69%
EPS beat(16)10
Avg EPS beat(16)-2.86%
Revenue beat(2)1
Avg Revenue beat(2)0.63%
Min Revenue beat(2)-1.24%
Max Revenue beat(2)2.49%
Revenue beat(4)1
Avg Revenue beat(4)0.09%
Min Revenue beat(4)-1.24%
Max Revenue beat(4)2.49%
Revenue beat(8)3
Avg Revenue beat(8)0.05%
Revenue beat(12)7
Avg Revenue beat(12)0.59%
Revenue beat(16)7
Avg Revenue beat(16)-0.06%
PT rev (1m)1.57%
PT rev (3m)0.31%
EPS NQ rev (1m)0.75%
EPS NQ rev (3m)0.86%
EPS NY rev (1m)3.54%
EPS NY rev (3m)2.94%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)0.45%
Revenue NY rev (1m)0.76%
Revenue NY rev (3m)0.68%
Valuation
Industry RankSector Rank
PE 14.56
Fwd PE 11.44
P/S 0.76
P/FCF 7.91
P/OCF 5.5
P/B N/A
P/tB N/A
EV/EBITDA 7.29
EPS(TTM)10.39
EY6.87%
EPS(NY)13.23
Fwd EY8.74%
FCF(TTM)19.12
FCFY12.64%
OCF(TTM)27.52
OCFY18.19%
SpS199.02
BVpS-9.5
TBVpS-122.8
PEG (NY)0.53
PEG (5Y)1.95
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 4.27%
ROE N/A
ROCE 14.02%
ROIC 11.22%
ROICexc 11.79%
ROICexgc 27.39%
OM 14.74%
PM (TTM) 5.47%
GM 32.25%
FCFM 9.61%
ROA(3y)4.59%
ROA(5y)4.56%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.38%
ROIC(5y)9.62%
ROICexc(3y)10.88%
ROICexc(5y)10.02%
ROICexgc(3y)24.5%
ROICexgc(5y)21.86%
ROCE(3y)12.97%
ROCE(5y)12.02%
ROICexgc growth 3Y20.64%
ROICexgc growth 5Y7.57%
ROICexc growth 3Y16.27%
ROICexc growth 5Y4.4%
OM growth 3Y9.25%
OM growth 5Y0.22%
PM growth 3Y4.31%
PM growth 5Y-3.96%
GM growth 3Y3.26%
GM growth 5Y0.9%
F-Score6
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 7.84
Debt/EBITDA 3.73
Cap/Depr 80.5%
Cap/Sales 4.22%
Interest Coverage 3.9
Cash Conversion 69.2%
Profit Quality 175.5%
Current Ratio 1.29
Quick Ratio 1.24
Altman-Z 1.54
F-Score6
WACC7.87%
ROIC/WACC1.43
Cap/Depr(3y)77.81%
Cap/Depr(5y)82.01%
Cap/Sales(3y)4.41%
Cap/Sales(5y)4.79%
Profit Quality(3y)182.58%
Profit Quality(5y)170.25%
High Growth Momentum
Growth
EPS 1Y (TTM)9.37%
EPS 3Y22.66%
EPS 5Y7.46%
EPS Q2Q%51.79%
EPS Next Y27.29%
EPS Next 2Y23.63%
EPS Next 3Y24.56%
EPS Next 5Y20.56%
Revenue 1Y (TTM)6.46%
Revenue growth 3Y5.53%
Revenue growth 5Y3.39%
Sales Q2Q%9.87%
Revenue Next Year3.76%
Revenue Next 2Y3.4%
Revenue Next 3Y3.7%
Revenue Next 5Y5.41%
EBIT growth 1Y2.85%
EBIT growth 3Y15.29%
EBIT growth 5Y3.61%
EBIT Next Year39.2%
EBIT Next 3Y15.52%
EBIT Next 5Y12.19%
FCF growth 1Y-10.63%
FCF growth 3Y10.89%
FCF growth 5Y0.09%
OCF growth 1Y-6.7%
OCF growth 3Y6.44%
OCF growth 5Y-0.95%

DAVITA INC / DVA FAQ

What is the ChartMill fundamental rating of DAVITA INC (DVA) stock?

ChartMill assigns a fundamental rating of 5 / 10 to DVA.


What is the valuation status of DAVITA INC (DVA) stock?

ChartMill assigns a valuation rating of 8 / 10 to DAVITA INC (DVA). This can be considered as Undervalued.


Can you provide the profitability details for DAVITA INC?

DAVITA INC (DVA) has a profitability rating of 7 / 10.


How financially healthy is DAVITA INC?

The financial health rating of DAVITA INC (DVA) is 3 / 10.


What is the expected EPS growth for DAVITA INC (DVA) stock?

The Earnings per Share (EPS) of DAVITA INC (DVA) is expected to grow by 27.29% in the next year.